Spexis Provides Update Regarding Debt-Restructuring Moratorium
Spexis AG / Key word: Miscellaneous Spexis Provides Update Regarding Debt-Restructuring Moratorium 29-Nov-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53...
Stay updated with breaking news from Jeff Wager. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spexis AG / Key word: Miscellaneous Spexis Provides Update Regarding Debt-Restructuring Moratorium 29-Nov-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53...
Spexis AG Key word Miscellaneous Spexis Provides Update Regarding DebtRestructuring Moratorium 29Nov2023 0715 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely resp
Ad hoc announcement pursuant to Art. 53 LR Spexis Provides Update Regarding Debt-Restructuring Moratorium Allschwil, Switzerland, November 29, 2023 Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that it is in discus...
Spexis AG Key word PersonnelPersonnel Spexis Announces Changes to the Executive Committee 01Nov2023 0720 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsib
Spexis provides business update and announces financial results for the first half of 2023...